Campbell Soup Company (CPB): AI Signals Bearish Opportunity

The Campbell's Company manufactures and markets branded food and beverage products, operating through two reportable segments. The 'Meals & Beverages' segment includes 'Campbell’s' soups, 'Swanson' broth, 'Pacific Foods' beverages, 'Prego' pasta sauces, 'Pace' Mexican sauces, 'SpaghettiOs' pasta, 'V8' juices, and 'Rao's' products acquired from Sovos Brands, targeting retail and foodservice markets in the U.S. and Canada. The 'Snacks' segment features 'Pepperidge Farm' cookies and crackers, 'Goldfish' crackers, 'Snyder’s of Hanover' pretzels, 'Lance' sandwich crackers, 'Cape Cod' potato chips, 'Kettle Brand' potato chips, 'Late July' snacks, and 'Snack Factory' pretzel crisps, primarily serving the U.S. retail market. The company's strategy focuses on maintaining strong brand recognition, taste, nutritional value, and innovation to compete with private label and other branded food manufacturers, emphasizing shelf space and customer service.

No relevant news was found for this stock today.

CPB's technical outlook is bearish. The stock price has declined significantly over the past 90 days, falling from approximately $33.90 in early September to around $29.77 as of November 4, 2025. The price is currently below its 50-day SMA, which sits around $31.84, and well below the 200-day SMA at $34.61, confirming the downtrend. Momentum indicators also point to weakness. The MACD is negative and trending downwards, with the MACD line below the signal line, suggesting further bearish momentum. The RSI is at 39.49, indicating oversold conditions, but not at a level that would typically trigger a strong reversal. The stochastic oscillator is also low, indicating oversold conditions, but the overall trend suggests that any bounce may be limited. The ADX is above 20, implying a strong trend. Recent price action confirms the downtrend, with lower highs and lower lows. Given these factors, the stock is likely to continue its downward trajectory over the next 1-3 months.

The Campbell's Company's MD&A presents a somewhat mixed picture. `Net sales` increased by 4% to $2.475 billion for the quarter, primarily due to the acquisition of Sovos Brands and favorable volume/mix, but this was partially offset by divestitures and lower net price realization. The `Gross profit` margin decreased to 29.4% from 30.9% in the prior-year quarter, influenced by cost inflation, supply chain costs, mark-to-market adjustments, and unfavorable net price realization, despite productivity improvements. For the nine-month period, the company generated cash flows from operations of $872 million in 2025, compared to $897 million in 2024, with the decline primarily due to changes in working capital. The company anticipates continued supply chain productivity and benefits from cost savings initiatives to mitigate inflationary pressures, but also expects economic pressures, including persistent inflation and impacts of tariffs, may continue to negatively impact volumes throughout 2025. Furthermore, the company recognized an impairment charge of $150 million on the Snyder's of Hanover trademark. The company's outlook is tempered by macroeconomic challenges and uncertainties surrounding tariffs and consumer behavior.

The Campbell Soup Company's Q4 fiscal 2025 earnings call presents a mixed outlook. While Q4 earnings were 'slightly ahead of our expectations,' the company anticipates headwinds in fiscal 2026, primarily due to tariffs. Organic net sales declined 3% in Q4, driven by shipment timing and pressure on snacking categories. Looking ahead, full-year reported net sales are expected to be down 2% to flat, and organic net sales are projected to be down 1% to up 1%. Adjusted EBIT is anticipated to decline 9% to 13%, and adjusted EPS is expected to be down 12% to 18%. According to Carrie Anderson, 'approximately two-thirds of the year-over-year decline in fiscal 2026 adjusted EPS guidance at the midpoint of the range is attributable to the estimated net tariff impact.' Despite these challenges, the company is intensifying its focus on cost savings, increasing its target to $375 million by the end of fiscal 2028. Management aims to mitigate the tariff impact through various actions, including inventory management, supplier collaboration, and surgical pricing actions, while also increasing marketing support and innovation across leadership brands, particularly in Meals & Beverages and Goldfish.

CPB's financial performance presents a somewhat positive but mixed picture. Revenue has fluctuated over the past year, starting at $2,518 million in Q1 2024 and ending at $2,321 million in Q4 2025, indicating some revenue volatility. The gross profit ratio has remained relatively stable, ranging from 0.294 to 0.316, suggesting consistent profitability on sales. Operating cash flow has varied, with the most recent quarter showing $271 million. Total debt has increased from $4,706 million in Q1 2024 to $7,212 million in Q4 2025, signaling increased financial leverage. Net income has seen significant fluctuations, from a high of $234 million in Q1 2024 to a low of -$3 million in Q4 2024, before recovering to $145 million in the most recent quarter. While the company is generating positive operating cash flow and has shown resilience in gross margins, the rising debt and inconsistent net income warrant caution. Overall, the company's financial health is neither strongly bullish nor bearish, requiring careful monitoring of debt levels and income stability.

The company presents a moderately bullish investment profile based on its key metrics and financial ratios. Revenue has shown positive growth, indicating a healthy demand for its products or services. The gross margin has remained relatively stable, suggesting efficient cost management. The Return on Equity (ROE) indicates a solid return for shareholders. The Price-to-Earnings (P/E) ratio suggests the company is appropriately valued by the market. The debt-to-equity ratio has seen a decrease, showcasing the company's improved financial leverage. The current ratio signifies the company's strong ability to meet its short-term obligations. Overall, the company demonstrates a stable and growing business model with a healthy balance sheet, making it a moderately attractive investment for the next 6-12 months.